Clincosm LogoSign in Get a demo

Prevalence of Stress Urinary Incontinence in Obese Versus Non-obese Nulligravid Women

Sponsor
Ain Shams University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05845320
Collaborator
(none)
200
Enrollment
7
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Urinary incontinence (UI) is more common than any other chronic disease. Stress urinary incontinence (SUI), among the various forms of urinary incontinence, is the most prevalent (50%) type of this condition. Female urinary continence is maintained through an integrated function of pelvic floor muscles (PFMs), fascial structures, nerves, supporting ligaments, and the vagina. In women with SUI, the postural activity of the PFMs is delayed, and the balance ability is decreased. Many women, by learning the correct timing of a pelvic floor contraction during a cough, are able to eliminate consequent SUI. Timing is an important function of motor coordination and could be affected by proprioception.

We aim to assess stress urinary incontinence in obese and non-obese Nulligravid females.

Condition or Disease Intervention/Treatment Phase
  • Other: ICIQ-UI SF questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Prevalence of Stress Urinary Incontinence in Obese Versus Non-obese Nulligravid Women
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Obese

BMI>30

Other: ICIQ-UI SF questionnaire
validated arabic short form of ICIQ on urinary incontinence
Non-obesse

BMI<25

Other: ICIQ-UI SF questionnaire
validated arabic short form of ICIQ on urinary incontinence

Outcome Measures

Primary Outcome Measures

  1. Prevalence of Stress Urinary Incontinence in Obese Versus Non-obese Nulligravid Women [6 months]

    as detected by questionnaire score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:

  • Women aged between18 and 45 years.

  • Non obese females with BMI <25kg/m2.

  • Obese females with BMI ≥30kg/m2.

  • Nulligravid females.

Exclusion Criteria:

  • Multiparous Females

  • Patients with active urinary tract infection.

  • Patients with respiratory or neurological diseases.

  • Patients with communication problems, cognitive disorders & mental disturbance.

  • Current treatment with drugs (benzodiazepines, diuretics)

  • Patients who underwent any previous abdominal or pelvic surgery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ain Shams University

Investigators

  • Principal Investigator: Maii Nawara, MD, Associate professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ain Shams University
ClinicalTrials.gov Identifier:
NCT05845320
Other Study ID Numbers:
  • MS 188/2023
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Urinary Incontinence
Enuresis
Urinary Incontinence, Stress

Study Results

No Results Posted as of May 6, 2023